Tufton Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,010
Closed -$1.59M 122
2019
Q3
$1.59M Sell
16,010
-1,140
-7% -$108K 0.34% 61
2019
Q2
$1.58M Sell
17,150
-75
-0.4% -$7.12K 0.34% 61
2019
Q1
$1.63M Buy
17,225
+132
+0.8% +$11.5K 0.35% 61
2018
Q4
$1.09M Sell
17,093
-1,134
-6% -$83.7K 0.27% 70
2018
Q3
$1.63M Sell
18,227
-497
-3% -$43.9K 0.35% 65
2018
Q2
$1.49M Sell
18,724
-1,014
-5% -$84.2K 0.32% 68
2018
Q1
$1.76M Buy
19,738
+2,354
+14% +$226K 0.35% 64
2017
Q4
$1.81M Buy
17,384
+104
+0.6% +$11.7K 0.35% 64
2017
Q3
$2.52M Sell
17,280
-142
-0.8% -$19.3K 0.5% 58
2017
Q2
$2.26M Buy
17,422
+2,247
+15% +$275K 0.46% 60
2017
Q1
$1.89M Sell
15,175
-497
-3% -$59.5K 0.37% 64
2016
Q4
$1.81M Sell
15,672
-432
-3% -$48.1K 0.37% 63
2016
Q3
$1.68M Sell
16,104
-37
-0.2% -$4K 0.34% 68
2016
Q2
$1.59M Sell
16,141
-1,409
-8% -$146K 0.32% 69
2016
Q1
$1.76M Sell
17,550
-546
-3% -$56.2K 0.44% 64
2015
Q4
$2.17M Sell
18,096
-1,291
-7% -$149K 0.53% 58
2015
Q3
$2.1M Sell
19,387
-885
-4% -$110K 0.46% 65
2015
Q2
$2.35M Sell
20,272
-21,858
-52% -$2.5M 0.47% 65
2015
Q1
$4.86M Buy
42,130
+120
+0.3% +$14.3K 0.89% 49
2014
Q4
$4.7M Sell
42,010
-85
-0.2% -$8.96K 0.86% 53
2014
Q3
$3.99M Buy
42,095
+51
+0.1% +$4.6K 0.75% 55
2014
Q2
$3.61M Buy
42,044
+344
+0.8% +$26.2K 0.73% 57
2014
Q1
$2.91M Buy
41,700
+4,988
+14% +$395K 0.61% 61
2013
Q4
$3.1M Sell
36,712
-7,218
-16% -$571K 0.66% 58
2013
Q3
$3.39M Sell
43,930
-114
-0.3% -$7.99K 0.8% 51
2013
Q2
$2.58M Buy
+44,044
New +$2.65M 0.62% 62

Other funds holding CELG

Tufton Capital Management's CELG Position: Q4 2019 in Review

Tufton Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,010 shares — an estimated $1.59M sold.

Tufton Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.86M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Tufton Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Tufton Capital Management sold 16,010 Celgene Corp shares in Q4 2019, an estimated $1.59M.
  • Tufton Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Tufton Capital Management's Celgene Corp position peaked at $4.86M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tufton Capital Management's 13F filing for Q4 2019, filed 24 Jan 2020.